Anti-GD2 Monoclonal Antibody (3F8)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anti-GD2 Monoclonal Antibody (3F8), covering 2013-01-18 to 2013-01-18. Get the full timeline:
Most recent: Clinical Trial Update: Beta-Glucan and Monoclonal Antibody in Treating Patients With Metastatic Neuroblastoma [Phase 1]